PROFESSIONAL DIVERSITY NETWO (IPDN)

US74312Y3018 - Common Stock

0.8001  +0.05 (+6.97%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to IPDN. IPDN was compared to 81 industry peers in the Professional Services industry. The financial health of IPDN is average, but there are quite some concerns on its profitability. IPDN is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

IPDN had negative earnings in the past year.
IPDN had a negative operating cash flow in the past year.
IPDN had negative earnings in each of the past 5 years.
In the past 5 years IPDN always reported negative operating cash flow.

1.2 Ratios

IPDN has a worse Return On Assets (-54.75%) than 93.51% of its industry peers.
Looking at the Return On Equity, with a value of -129.30%, IPDN is doing worse than 87.01% of the companies in the same industry.
Industry RankSector Rank
ROA -54.75%
ROE -129.3%
ROIC N/A
ROA(3y)-45.63%
ROA(5y)-49.07%
ROE(3y)-114.11%
ROE(5y)-124.55%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

IPDN's Gross Margin of 60.38% is fine compared to the rest of the industry. IPDN outperforms 67.53% of its industry peers.
IPDN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for IPDN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.38%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.54%
GM growth 5Y-8.72%

4

2. Health

2.1 Basic Checks

IPDN does not have a ROIC to compare to the WACC, probably because it is not profitable.
IPDN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, IPDN has more shares outstanding
IPDN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -23.65, we must say that IPDN is in the distress zone and has some risk of bankruptcy.
IPDN has a worse Altman-Z score (-23.65) than 98.70% of its industry peers.
There is no outstanding debt for IPDN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -23.65
ROIC/WACCN/A
WACC9.07%

2.3 Liquidity

IPDN has a Current Ratio of 0.57. This is a bad value and indicates that IPDN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.57, IPDN is doing worse than 93.51% of the companies in the same industry.
IPDN has a Quick Ratio of 0.57. This is a bad value and indicates that IPDN is not financially healthy enough and could expect problems in meeting its short term obligations.
IPDN's Quick ratio of 0.57 is on the low side compared to the rest of the industry. IPDN is outperformed by 93.51% of its industry peers.
Industry RankSector Rank
Current Ratio 0.57
Quick Ratio 0.57

1

3. Growth

3.1 Past

IPDN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.65%, which is quite impressive.
IPDN shows a decrease in Revenue. In the last year, the revenue decreased by -6.87%.
IPDN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.21% yearly.
EPS 1Y (TTM)41.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.09%
Revenue 1Y (TTM)-6.87%
Revenue growth 3Y19.96%
Revenue growth 5Y0.21%
Sales Q2Q%-8.13%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IPDN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

IPDN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PROFESSIONAL DIVERSITY NETWO

NASDAQ:IPDN (11/22/2024, 8:00:02 PM)

0.8001

+0.05 (+6.97%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap10.51M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -54.75%
ROE -129.3%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 60.38%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.57
Quick Ratio 0.57
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)41.65%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-6.87%
Revenue growth 3Y19.96%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y